We are live on ! Find out more
SCM

Stevens Capital Management Portfolio holdings

AUM $649M
1-Year Est. Return 27.37%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$3.73B
AUM Growth
+$36.2M
Cap. Flow
-$5.17M
Cap. Flow %
-0.14%
Top 10 Hldgs %
11.3%
Holding
1,547
New
510
Increased
264
Reduced
248
Closed
521

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.4M
2
QCOM icon
Qualcomm
QCOM
+$44.3M
3
UNP icon
Union Pacific
UNP
+$41.1M
4
EBAY icon
eBay
EBAY
+$40.2M
5
BAX icon
Baxter International
BAX
+$36.2M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$42M
2
CELG
Celgene Corp
CELG
+$41.2M
3
GS icon
Goldman Sachs
GS
+$39.5M
4
HON icon
Honeywell
HON
+$37M
5
FDX icon
FedEx
FDX
+$34M

Sector Composition

Rank Sector Weight
1 Financials 14.67%
2 Industrials 14.62%
3 Consumer Discretionary 12.35%
4 Energy 10.18%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OME
976
DELISTED
Omega Protein
OME
$138K ﹤0.01%
10,058
-2,806
-22% -$36.7K
INFN
977
DELISTED
Infinera Corporation Common Stock
INFN
$136K ﹤0.01%
+14,779
New +$131K
SMA
978
DELISTED
SYMMETRY MEDICAL INC
SMA
$135K ﹤0.01%
15,200
-3,072
-17% -$26.8K
ICA
979
DELISTED
EMPRESAS ICA, S.A. DE C.V. ADS (EA REPTG 4 ORD PART CERT)
ICA
$135K ﹤0.01%
+17,235
New +$129K
AGI icon
980
Alamos Gold
AGI
$12.2B
$134K ﹤0.01%
+13,237
New +$121K
OREX
981
DELISTED
Orexigen Therapeutics, Inc.
OREX
$134K ﹤0.01%
2,176
-1,288
-37% -$74.9K
CEMP
982
DELISTED
Cempra, Inc.
CEMP
$132K ﹤0.01%
+12,309
New +$119K
NKTR icon
983
Nektar Therapeutics
NKTR
$2.36B
$131K ﹤0.01%
681
-545
-44% -$96.4K
GSIG
984
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$131K ﹤0.01%
+10,304
New +$130K
DAKT icon
985
Daktronics
DAKT
$952M
$124K ﹤0.01%
10,379
-4,618
-31% -$59.9K
HALO icon
986
Halozyme
HALO
$9.92B
$123K ﹤0.01%
12,480
-2,890
-19% -$24.5K
AUQ
987
DELISTED
AURICO GOLD INC COM
AUQ
$123K ﹤0.01%
+28,823
New +$117K
BFX
988
DELISTED
BowFlex Inc.
BFX
$122K ﹤0.01%
+11,025
New +$112K
MCP
989
DELISTED
MOLYCORP INC COM STK
MCP
$122K ﹤0.01%
47,453
+29,916
+171% +$108K
BDSI
990
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$122K ﹤0.01%
+10,089
New +$95.7K
ATSG
991
DELISTED
Air Transport Services Group
ATSG
$121K ﹤0.01%
+14,490
New +$122K
EJ
992
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$120K ﹤0.01%
14,915
+943
+7% +$8.28K
SBCF icon
993
Seacoast Banking Corp of Florida
SBCF
$3.27B
$119K ﹤0.01%
10,948
+550
+5% +$5.85K
ARC
994
DELISTED
ARC Document Solutions, Inc.
ARC
$119K ﹤0.01%
20,322
+380
+2% +$2.4K
RTEC
995
DELISTED
Rudolph Technologies Inc
RTEC
$115K ﹤0.01%
11,630
-1,654
-12% -$16.4K
LSAK icon
996
Lesaka Technologies
LSAK
$393M
$114K ﹤0.01%
+10,015
New +$103K
IIP
997
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$112K ﹤0.01%
15,876
+296
+2% +$2.09K
NOR
998
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$108K ﹤0.01%
+4,352
New +$109K
UMC icon
999
United Microelectronic
UMC
$43.9B
$107K ﹤0.01%
44,243
-16,932
-28% -$37.8K
JCP
1000
DELISTED
J.C. Penney Company, Inc.
JCP
$105K ﹤0.01%
+11,602
New +$100K
38 39
40
41 42

Similar funds

CCA
Carrera Capital Advisors Troy, Michigan $649M AUM 19.82% 1-Year Est. Return
HPIA
Hamilton Point Investment Advisors Chapel Hill, North Carolina $649M AUM 15.81% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $649M AUM
TWP
Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
CAAM
Cornerstone Advisors Asset Management Bethlehem, Pennsylvania $648M AUM 11.43% 1-Year Est. Return
RK
Rather & Kittrell Knoxville, Tennessee $648M AUM 14.68% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return

Stevens Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Stevens Capital Management held 1,547 positions worth $3.73B, up 0.98% from $3.69B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Stevens Capital Management's Q2 2014 filing shows 510 new, 264 increased, 248 reduced and 521 closed positions. Its largest new stake was Pfizer: 1,593,770 shares worth $44.9M. The largest sale was Chevron, an estimated $42M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Stevens Capital Management's largest Q2 2014 buy was Pfizer: 1,593,770 shares worth $44.9M.
  • Stevens Capital Management added most to ExxonMobil in Q2 2014, an estimated $34.2M increase.
  • Stevens Capital Management's biggest Q2 2014 reduction was FedEx, cutting an estimated $34M.
  • Stevens Capital Management fully exited Chevron in Q2 2014, selling an estimated $42M.
  • Stevens Capital Management's ten largest holdings make up 11% of its $3.73B portfolio in Q2 2014.
  • Stevens Capital Management opened 510 new positions and closed 521 in Q2 2014.
  • Stevens Capital Management's portfolio value rose 0.98% quarter-over-quarter to $3.73B.

Based on Stevens Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.